Search

everythinglearnresearchcommunity

for

Search:↓

New compounds were made that effectively block a specific enzyme related to androgen conditions.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

3-tetrazolo steroidal analogs can strongly inhibit the enzyme linked to hair loss.

Scientists found new, better-working inhibitors for a hormone-related enzyme.

New topical treatment using spherical nucleic acids shows promise in reducing psoriasis inflammation.

Compound N4 effectively kills breast cancer cells and compounds N2 and N3 have strong antibacterial and antifungal properties.

Minoxidil analogs can be improved for hair growth inhibition by modifying specific parts of their structure.

Mimicking the steroid A-ring may help create effective enzyme inhibitors for prostate disease treatment.

Researchers made new compounds that could potentially be developed into anticancer drugs.

Scientists created iodinated arylhydantoins and arylthiohydantoins that could potentially be used for imaging prostate cancer. Some versions with specific side-chains showed high potential for this use.

Certain compounds, especially those with a propionic substituent, could potentially be new treatments for hair loss and similar disorders.

The research created new azasteroids and pseudoazulenyl nitrones, which could be useful in medicine.

Pyrene excimer nucleic acid probes are promising for detecting biomolecules accurately with potential for biological research and drug screening.

New curcumin analogues help fight prostate cancer by breaking down androgen receptors.

Polynucleotides effectively promote hair regrowth in androgenetic alopecia without serious side effects.

New method makes important drug ingredients more easily without needing extra purification steps.

2-Hydroxy-1,4-naphthoquinone is a strong 5α-reductase inhibitor.

The salts have diverse molecular packing with significant hydrogen interactions.

The compound 4c showed strong potential as an anticancer agent.

New testosterone analogs show promise for male contraception with better activity and potentially fewer side effects.

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

Compound 1 showed promising anticancer activity.

Polynucleotides improve skin quality and are safe and effective for rejuvenation.

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

Cepharanthine analogues, especially tetrandrine, show potential for treating COVID-19.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

Aptamers can improve wound healing and promote hair growth.